Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05075850 · ClinicalTrials.gov registry record
PatiEnt Neuropsychological outcomeS After laseR Ablation
A clinical trial, sponsored by Monteris Medical.
- Completed
- Registry status
- 81
- Enrollment target
NCT05075850: Completed study, sponsored by Monteris Medical.
NCT05075850 is a clinical trial that has completed, run by Monteris Medical. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05075850 has completed, sponsored by Monteris Medical.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
PatiEnt Neuropsychological outcomeS After laseR ablation
Primary Outcome
Neuropsychological test data collected will describe cognitive domain specific changes as a cohort. Change will be assessed from raw test scores and demographically corrected standardized scores (where available). For this study, collected cognitive domains include Language (Boston Naming Test), Executive Function (Trails Making Test), Attention (Wechsler Adult Intelligence Scale 3 Digital Span Test), Verbal Memory (Logical Memory Test), Visual Memory (Brief Visiospacial Memory Test), Verbal Flu
Interventions
- DEVICE Neuroblate System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2023-09-30 |
What the finished NCT05075850 record still lists
NCT05075850 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Neuroblate System is the first listed.
NCT05075850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05075850 about?
NCT05075850 is a clinical study titled "PatiEnt Neuropsychological outcomeS After laseR Ablation". PatiEnt Neuropsychological outcomeS After laseR ablation
What is the current status of trial NCT05075850?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2021-09-29. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT05075850?
The interventions under investigation include: Neuroblate System (DEVICE).
Who is sponsoring clinical trial NCT05075850?
This trial is sponsored by Monteris Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI